Patient Guide: A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 28 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT04721977
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 28 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Nagoya, Aichi-ken
  • • Nagoya, Aichi-ken
  • • Kashiwa, Chiba
  • • And 25 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Tucatinib (MK-7119) in Combination With Trastuzumab and Capecitabine in Participants With Previously Treated Locally Advanced Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Breast Carcinoma (MK-7119-001) - Join Clinical Trial NCTNCT04721977

How to Join This Clinical Trial - NCTNCT04721977

Learn how to participate in this PHASE2 trial studying an investigational therapy for Breast Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04721977 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Nagoya, Aichi-ken 464-8681 - Japan

Status: Contact for availability

Clinical Research Site

Nagoya, Aichi-ken 466-8560 - Japan

Status: Contact for availability

Clinical Research Site

Kashiwa, Chiba 2778577 - Japan

Status: Contact for availability

Clinical Research Site

Matsuyama, Ehime 791-0280 - Japan

Status: Contact for availability

Clinical Research Site

Sapporo, Hokkaido 003-0804 - Japan

Status: Contact for availability

Clinical Research Site

Sapporo, Hokkaido 060-8648 - Japan

Status: Contact for availability

Clinical Research Site

Akashi, Hyōgo 673-8558 - Japan

Status: Contact for availability

Clinical Research Site

Nishinomiya, Hyōgo 663-8501 - Japan

Status: Contact for availability

Clinical Research Site

Tsukuba, Ibaraki 305-8576 - Japan

Status: Contact for availability

Clinical Research Site

Yokohama, Kanagawa 241-8515 - Japan

Status: Contact for availability

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation